Table 1 Selected baseline characteristic of patients enrolled in SPRINT-2, all treatment arms combined [17]
Characteristics | Combined cohorts (N = 1097) |
|---|---|
Race Cohort, no. (%) | Â |
  Black | 159 (14.5) |
  Non-Black | 938 (85.5) |
Age, mean (standard deviation), years | 49.1 (9.4) |
Male sex, no. (%) | 656 (60) |
METAVIR Score, without missing data, no (%) | N = 1060 |
  F0 – no fibrosis | 47 (4.4) |
  F1 – portal fibrosis without septa, | 730 (68.9) |
  F2 – portal fibrosis with few septa | 183 (17.3) |
  F3 – numerous septa without cirrhosis | 47 (4.4) |
  F4 – cirrhosis | 53 (5) |